Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-11-01Clinical Trial Update: Pharmacokinetics Study of Oral IXAZOMIB in Participants With Advanced Nonhematologic Malignancies or Lymphoma [Phase 1]
Phase 1 pharmacokinetics results for oral ixazomib in participants with advanced nonhematologic malignancies or lymphoma have been completed…
-
CLINICAL_TRIALS trial_result · 2017-10-27Clinical Trial Update: Samsung Medical Center-Lymphoma Cohort Study-II
A completed clinical trial update for the Samsung Medical Center Lymphoma Cohort Study II. The study focusing on lymphoma has reached comple…
-
CLINICAL_TRIALS trial_result · 2017-10-17Clinical Trial Update: Proton Radiation for Lymphoma Involving Mediastinum [NA]
A clinical trial evaluating proton radiotherapy for mediastinal lymphoma (NCT01751412) was terminated, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-10-12Clinical Trial Update: Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer [Phase 1]
Phase 1 study evaluating low-dose fludarabine, busulfan, and anti-thymocyte globulin conditioning followed by donor umbilical cord blood tra…
-
CLINICAL_TRIALS trial_result · 2017-10-02Clinical Trial Update: Alefacept in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma or Peripheral T-Cell Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 clinical trial evaluating alefacept in relapsed or refractory cutaneous T-cell lymphoma and peripheral T-cell non-Hodgkin's lymphoma…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-09-28Clinical Trial Update: Rituximab, Cyclophosphamide, and G-CSF Followed By Combination Chemotherapy in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant Followed By Rituximab and GM-CSF for Refractory Diffuse Large B-Cell Lymphoma [Phase 2]
Phase 2 trial evaluating rituximab, cyclophosphamide, and G-CSF followed by combination chemotherapy with rituximab and GM-CSF for refractor…
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies [Phase 1, Phase 2]
Phase 1/2 study of oral LBH589 (panobinostat) in adults with advanced hematologic malignancies completed; results posted.
-
CLINICAL_TRIALS trial_result · 2017-08-03Clinical Trial Update: Infusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T Cells [Phase 1]
A Phase 1 study evaluating infusion of allogeneic cord blood-derived CD19-specific T cells for leukemia and lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-31Clinical Trial Update: A Pilot Study of Recombinant Human Arginase 1 (rhArg1) in Patients With Relapsed or Refractory Leukemia or Lymphoma [Phase 1]
Phase 1 trial of Recombinant Human Arginase 1 (rhArg1) in relapsed or refractory leukemia or lymphoma has been terminated. This status updat…
-
CLINICAL_TRIALS trial_result · 2017-07-25Clinical Trial Update: Phase I Open-Label, Dose-Escalation Study of GSK1059615 in Patients With Solid Tumors or Lymphoma [Phase 1]
Phase I open-label dose-escalation trial of the investigational compound GSK1059615 in patients with solid tumors or lymphoma was terminated…
-
CLINICAL_TRIALS trial_result · 2017-07-19Clinical Trial Update: Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer [Phase 1]
A Phase 1 trial of fenretinide in patients with refractory or relapsed hematologic cancers has been completed, investigating safety across m…
-
CLINICAL_TRIALS trial_result · 2017-07-17Clinical Trial Update: Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen [Phase 1, Phase 2]
A Phase 1/2 trial evaluating allogeneic hematopoietic cell transplantation using a busulfan-based conditioning regimen across multiple hemat…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: A Phase I Study of Vorinostat and Bortezomib in Children With Refractory of Recurrent Solid Tumors, Including CNS Tumors and Lymphomas [Phase 1]
This Phase I trial evaluated the combination of vorinostat and bortezomib in pediatric patients with refractory or recurrent solid tumors, i…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Evaluation of Late Treatment Effects in Long-Term Survivors of Hodgkin's Disease Previously Treated at NIH: A Multi-Institutional Trial
A completed multi-institutional NIH study evaluated late treatment effects in long-term survivors of Hodgkin lymphoma, investigating long-te…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: CDDO to Treat Solid Tumors and Lymphomas [Phase 1]
The National Cancer Institute-sponsored Phase 1 trial evaluated CDDO in patients with solid tumors and lymphoma; the study has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating busulfan, fludarabine, and total-body irradiation as conditioning for donor stem cell transplantation …
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: SNX-5422 to Treat Solid Tumor Cancers and Lymphomas [Phase 1]
Phase 1 trial results for SNX-5422 in solid tumors and lymphomas have completed.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines [Phase 1]
A Phase 1 trial evaluated a tumor-derived immunoglobulin idiotype antigen vaccine for follicular lymphoma. The trial status indicates comple…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Safety Study of ABT-888 Plus Topotecan Hydrochloride to Treat Patients With Solid Tumors and Lymphomas [Phase 1]
The document reports the completion of a Phase 1 safety study evaluating veliparib (ABT-888) in combination with topotecan hydrochloride for…
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant [Phase 2]
This Phase 2 trial evaluated sirolimus, tacrolimus, and antithymocyte globulin to prevent graft-versus-host disease in patients with hematol…
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma [Phase 2]
Phase 2 trial update evaluating rituximab with combination chemotherapy in primary central nervous system lymphoma; study terminated with re…
-
CLINICAL_TRIALS trial_result · 2017-06-27Clinical Trial Update: Simultaneous Care: Linking Palliation to Clinical Trials [NA]
This is a completed clinical trial update from the University of California, Davis about linking palliation to participation in clinical tri…
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: A Study to Determine the Metabolism and Elimination of 14C-E7080 in Patients With Advanced Solid Tumors or Lymphomas, Who Are Unsuitable For, or Have Failed, Existing Therapies. [Phase 1]
Phase 1 study assessing how radiolabeled E7080 (lenvatinib) is metabolized and eliminated in patients with advanced solid tumors or lymphoma…
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other Disease [Phase 2]
Phase 2 trial update describing donor umbilical cord blood transplantation for advanced hematologic cancers, including leukemia, lymphoma, m…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease [Phase 2]
Phase 2 trial evaluating reduced-intensity conditioning with busulfan and fludarabine, with or without antithymocyte globulin, followed by d…